Both exenatide and liraglutide are relatively well tolerated, with dose-dependent nausea, vomiting, and diarrhea being the most commonly reported adverse events observed in clinical trials
Key considerations if a patient discloses combined use include: Gastrointestinal effects : Both agents may independently cause nausea, vomiting, or appetite suppression
By targeting these two hormone pathways simultaneously, tirzepatide offers a unique approach to weight loss that goes beyond the capabilities of existing medications like Ozempic or Wegovy
Common symptoms linked to low vitamin B12 may include: Persistent tiredness or fatigue Low energy Brain fog or poor concentration Dizziness or feeling faint Weakness Mood changes Pins and needles Numbness or tingling in hands and feet Pale or slightly yellow skin These symptoms can overlap with other health conditions, which is why professional guidance is important
But, while we wait for conclusive evidence, the potential risk remains for people who rely on their pills and who are considering GLP-1 treatments
Semaglutide may reduce the urge to overeat or indulge in highly rewarding foods, possibly by dampening the dopamine-driven reward response in the brain, which reduces food cravings and enhances weight management efforts